Camouflaging endovascular stents with an endothelial coat using CD31 domain 1 and 2 mimetic peptides by Sénémaud, Jean, Skarbek, Charles, Hernandez, Belen, Song, Ran, Lefevre, Isabelle, Bianchi, Elisabetta, Castier, Yves, Nicoletti, Antonino, Bureau, Christophe, Caligiuri, Giuseppina

Get full text

Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects by Delahousse, Julia, Skarbek, Charles, Desbois, Mélanie, Perfettini, Jean-Luc, Chaput, Nathalie, Paci, Angelo

Get full text

Between the Devil and the Deep Blue Sea: New Insights into the Effects of Cancer Therapy on Abdominal Aortic Aneurysm Growth by Sénémaud, Jean, Skarbek, Charles

Get full text

Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment by Maslah, Hichem, Skarbek, Charles, Pethe, Stéphanie, Labruère, Raphaël

Get full text

CD31 Coated Surfaces Enhance Endothelialisation and Reduce Platelet Adhesion: A Promising Strategy for Improving Stent Graft Biocompatibility by Senemaud, Jean, Skarbek, Charles, Song, Tina, Pan, Zongcheng, Bureau, Christophe, Caligiuri, Giuseppina

Get full text

Synthesis of 6-methylphenanthridines and evaluation against human papillomavirus-related endocervical adenocarcinoma (KB 3.1) cells by Maslah, Hichem, Skarbek, Charles, Labruère, Raphaël

Get full text

In‐Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development by Maslah, Hichem, Skarbek, Charles, Gourson, Catherine, Plamont, Marie‐Aude, Pethe, Stéphanie, Jullien, Ludovic, Le Saux, Thomas, Labruère, Raphaël

Get full text

Molecular Imaging of Experimental Abdominal Aortic Aneurysms Targeting Vascular Homeostasis Disruption via CD31 Shedding by Sénémaud, Jean N., Skarbek, Charles, Vigne, Jonathan, Rouzet, Francois, Castier, Yves, Caligiuri, Giuseppina

Get full text

Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer by Skarbek, Charles, Serra, Silvia, Maslah, Hichem, Rascol, Estelle, Labruère, Raphaël

Get full text

Re-designing environmentally persistent pharmaceutical pollutant through programmed inactivation: The case of methotrexate by Espinosa, Anaïs, Rascol, Estelle, Abellán Flos, Marta, Skarbek, Charles, Lieben, Pascale, Bannerman, Eva, Martinez, Alba Diez, Pethe, Stéphanie, Benoit, Pierre, Nélieu, Sylvie, Labruère, Raphaël

Get full text

Photodegradation of methotrexate in aqueous solution: degradation kinetics and identification of transformation products by Espinosa, Anaïs, Nélieu, Sylvie, Lieben, Pascale, Skarbek, Charles, Labruère, Raphaël, Benoit, Pierre

Get full text

Structural modification and biological activity studies of tagitinin C and its derivatives by Au, Thi Hang, Skarbek, Charles, Pethe, Stephanie, Labruere, Raphael, Baltaze, Jean-Pierre, Nguyen, Thi Phuong Hoa, Vu, Thi Thu Ha, Vo-Thanh, Giang

Get full text

Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies by Skarbek, Charles, Delahousse, Julia, Pioche-Durieu, Catherine, Baconnais, Sonia, Deroussent, Alain, Renevret, Patrice, Rivard, Michael, Desmaele, Didier, Martens, Thierry, Le Cam, Eric, Couvreur, Patrick, Paci, Angelo

Get full text

Abstract 2194: New oxazaphosphorine prodrugs for immunotherapy and nanomedicine against cancer by Skarbek, Charles, Gonde, Henri, Desbois, Mélanie, Delahousse, Julia, Chaput-Gras, Nathalie, Benoit, Jean-Pierre, Roger, Emilie, Paci, Angelo

Get full text

Abstract 2195: Combined strategy based on pre-activated analogs of oxazaphosphorines for increased therapeutic index and immune modulation by Delahousse, Julia, Skarbek, Charles, Gauthier, Valentine, Desbois, M, Roger, Emilie, Pioche-Durieu, C., Rivard, M., Desmaële, D., Martens, T., LeCam, E., Benoit, Jean-Pierre, Couvreur, P., Chaput-Gras, Nathalie, Paci, Angelo

Get full text

In‐Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development by Maslah, Hichem, Skarbek, Charles, Gourson, Catherine, Plamont, Marie‐Aude, Pethe, Stéphanie, Jullien, Ludovic, Le Saux, Thomas, Labruère, Raphaël

Get full text

Abstract 4537: Geranyloxy-ifosfamide: A pre-activated ifosfamide analogue showing an increased therapeutic index by Skarbek, Charles, Desmaele, Didier, Deroussent, Alain, Lesueur, Lea, Daudigeos-Dubus, Estelle, Le Dret, Ludivine, Rivard, Michael, Martens, Thierry, Vassal, Gilles, Couvreur, Patrick, PACI, Angelo

Get full text

Simultaneous quantification of preactivated ifosfamide derivatives and of 4-hydroxyifosfamide by high performance liquid chromatography–tandem mass spectrometry in mouse plasma and... by Deroussent, Alain, Skarbek, Charles, Maury, Adeline, Chapuis, Hubert, Daudigeos-Dubus, Estelle, Le Dret, Ludivine, Durand, Sylvère, Couvreur, Patrick, Desmaële, Didier, Paci, Angelo

Get full text

Preactivated Oxazaphosphorines Designed for Isophosphoramide Mustard Delivery as Bulk Form or Nanoassemblies: Synthesis and Proof of Concept by Skarbek, Charles, Lesueur, Lea L, Chapuis, Hubert, Deroussent, Alain, Pioche−Durieu, Catherine, Daville, Aurore, Caron, Joachim, Rivard, Michael, Martens, Thierry, Bertrand, Jean-Rémi, Le Cam, Eric, Vassal, Gilles, Couvreur, Patrick, Desmaele, Didier, Paci, Angelo

Get full text

Abstract 5671: Enhanced activity of pre-activated oxazaphosphorine prodrugs designed for drug delivery strategy: influence of the length of the engrafted group by Skarbek, Charles, Chapuis, Hubert, Lesueur, Léa, Rivard, Michael, Martens, Thierry, Desmaele, Didier, Daudigeos-Dubus, Estelle, Bertrand, Jean-Rémi, Deroussent, Alain, Vassal, Gilles, Couvreur, Patrick, Paci, Angelo

Get full text